Pfizer, BioNTech to supply up to 1.8 bln additional doses of COVID-19 vaccine to EU
Topics: PFIZER BIONTECH
As part of the deal, the EC also has an option to increase the number of doses delivered by up to an additional 900 million.
The latest deal is in addition to the 600 million doses that have already been committed to the EU through 2021. The total number of potential doses delivered to the EC, inclusive of all agreements, would be up to 2.4 billion.
The companies plan to manufacture all doses for the EC in the European Union. The additional 900 million agreed doses will delivered on a monthly schedule beginning December 2021 and continuing into 2023. ■